Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
20.8 USD | -1.05% | +5.53% | -10.92% |
30/04 | Akero Therapeutics Appoints Scott Gangloff as Chief Technology Officer | CI |
08/03 | Akero Therapeutics Raises $367 Million From Share Offering | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-10.92% | 1.45B | |
+2.97% | 108B | |
+10.21% | 105B | |
+1.57% | 23.46B | |
-12.77% | 21.72B | |
-7.05% | 18.64B | |
-37.64% | 17.45B | |
-6.50% | 17.19B | |
+6.00% | 13.99B | |
+37.20% | 12.53B |
- Stock Market
- Equities
- AKRO Stock
- News Akero Therapeutics, Inc.
- Cantor Fitzgerald Initiates Akero Therapeutics at Overweight With $69 Price Target